The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 07, 2020
Filed:
Dec. 13, 2016
Applicant:
Glaxosmithkline Biologicals SA, Rixensart, BE;
Inventors:
Dominique Ingrid Lemoine, Rixensart, BE;
Nicolas Moniotte, Maryland, MD (US);
Assignee:
GLAXOSMITHKLINE BIOLOGICALS SA, Rixensart, BE;
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/12 (2006.01); A61K 39/015 (2006.01); A61K 9/127 (2006.01); A61K 9/19 (2006.01); A61K 39/29 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0015 (2013.01); A61K 9/1275 (2013.01); A61K 9/19 (2013.01); A61K 39/00 (2013.01); A61K 39/015 (2013.01); A61K 39/12 (2013.01); A61K 39/29 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/55577 (2013.01); A61K 2039/6075 (2013.01); C07K 2319/00 (2013.01); C12N 2710/16734 (2013.01); Y02A 50/412 (2018.01);
Abstract
Described herein is the formulation of immunogenic or vaccine compositions comprising neutral lipid liposome based adjuvants, where the composition is suitable for lyophilisation. In particular, the invention relates to lyophilised forms of such immunogenic or vaccine compositions wherein both the immunogen or vaccine antigen and the adjuvant are present in one and the same vial, as well as to the formulation and manufacture of lyophilised forms of such immunogenic or vaccine composition.